Asset

UMBRALISIB TOSYLATE

TG Therapeutics Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 213176NDATG THERAPEUTICS INC

Marketed products (1)

  • UKONIQ